Exenatide Activates the APPL1-AMPK-PPAR Axis to Prevent Diabetic Cardiomyocyte Apoptosis
Keep reading Published on: February 01, 2021 High-Tech Cancer Care at Wellstar At Wellstar, we treat more than patients
Renoprotective effect of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in streptozotocin-induced type 1 diabetic mice
GLP-1 Microdosing refers to the use of lower-than-standard doses of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) or liraglutide (Victoza, Saxenda)
The cost of GLP-1 medications to treat obesity has helped drive large increases in pharmacy trends over the last three years, and despite the clear clinical benefits of this drug class, some employers and plan sponsors have chosen to discontinue coverage due to cost concerns
Clinical effectiveness of currently used antidepressant drugs, which target monoaminergic systems in the brain mainly by enhancing serotoninergic and noradrenergic neurotransmission, is very often low and insufficient since approximately only one-third of the patients achieve complete remission of depressive symptoms after therapy